Early aspirin use and the development of cardiac allograft vasculopathy

M Kim, BA Bergmark, TA Zelniker, MR Mehra… - The Journal of Heart and …, 2017 - Elsevier
Background Cardiac allograft vasculopathy (CAV) remains a leading cause of morbidity and
mortality after orthotopic heart transplantation (OHT). Little is known about the influence of …
被引用次数：45 相关文章

Early aspirin use and the development of cardiac allograft vasculopathy

M Kim, BA Bergmark, TA Zelniker, MR Mehra… - The Journal of Heart …, 2017 - jhltonline.org
Background Cardiac allograft vasculopathy (CAV) remains a leading cause of morbidity and
mortality after orthotopic heart transplantation (OHT). Little is known about the influence of …

Early aspirin use and the development of cardiac allograft vasculopathy

M Kim, BA Bergmark, TA Zelniker… - The Journal of …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Cardiac allograft vasculopathy (CAV) remains a leading cause of morbidity and
mortality after orthotopic heart transplantation (OHT). Little is known about the influence of …

Early aspirin use and the development of cardiac allograft vasculopathy.

M Kim, BA Bergmark, TA Zelniker… - The Journal of Heart …, 2017 - europepmc.org
Background Cardiac allograft vasculopathy (CAV) remains a leading cause of morbidity and
mortality after orthotopic heart transplantation (OHT). Little is known about the influence of …